Skip to main content

Transfusional Medicine

We are dedicated to investigate transfusional activity, the alteration of erythrocytes during the conservation period and extracorporeal photoapheresis. We work on the molecular and serological characterization of blood group variants. In non-invasive fetal genotyping strategies due to blood group incompatibilities. We develop iPSC lines and produce in vitro erythrocytes with rare phenotypes.

We deepen in the knowledge of epidemiology and the detection of infectious agents relevant for safety of the products supplied by the Blood and Tissue Bank.

We investigate in clinical immunology and develop our own HLA and KIR typing protocols. We develop and incorporate new therapeutic applications in cell therapy including hematopoietic transplantation, cellular immunology and regenerative medicine.

We investigate the molecular mechanisms and genotype-phenotype correlation of coagulopathies, haemorrhagic diathesis and other associated congenital pathologies. We develop tools based on the new technologies of parallel massive sequencing with application to the molecular study, genetic counselling and prenatal diagnosis.

Team

Sara Morini

Sara Morini

Postdoctoral researcher
Transfusional Medicine
Read more
Alejandro Madrigal Fernandez

Alejandro Madrigal Fernandez

Read more
Angie Rico Blazquez

Angie Rico Blazquez

Research technician
Transfusional Medicine
Read more
Belen Alvarez Palomo

Belen Alvarez Palomo

Postdoctoral researcher
Transfusional Medicine
Read more
Carina Lera Asensio

Carina Lera Asensio

Research technician
Transfusional Medicine
Read more
Carlos Hobeich Naya

Carlos Hobeich Naya

Research technician
Transfusional Medicine
Read more
Sara Morini

Sara Morini

Postdoctoral researcher
Transfusional Medicine
Read more
Alejandro Madrigal Fernandez

Alejandro Madrigal Fernandez

Read more
Angie Rico Blazquez

Angie Rico Blazquez

Research technician
Transfusional Medicine
Read more
Belen Alvarez Palomo

Belen Alvarez Palomo

Postdoctoral researcher
Transfusional Medicine
Read more
Carina Lera Asensio

Carina Lera Asensio

Research technician
Transfusional Medicine
Read more
Carlos Hobeich Naya

Carlos Hobeich Naya

Research technician
Transfusional Medicine
Read more

Research lines

Biological safety

Epidemiology and detection of infectious agents relevant for the safety of the products supplied by the Blood and Tissue Bank. PI: Piron, Maria Researchers: Casamitjana Ponces, Natàlia Researchers in training: De la Torre Rial, Carmen

IP: -

Cell therapy

Development and incorporation of new therapeutic applications in the area of ??cell therapy including hematopoietic transplantation, cellular immunology and regenerative medicine. PI: Querol Giner, Sergi Researchers: García Gómez, Susana Rodríguez Gómez, Luciano Researchers in training: Samarkanova, Dinara Enrich Randés, Emma Lopez Montañes, Maria Nursing, technical and administrative staff: Lopez Montañes, Maria Ribo, Nuria

IP: -

Congenital coagulopathies

Investigation in the molecular mechanisms and the genotype-phenotype correlation of coagulopathies, hemorrhagic diathesis and other associated congenital pathologies. Development of tools based on the new technologies of parallel massive sequencing with application to the molecular study, genetic counselling and prenatal diagnosis. PI: Parra López, Rafael and Vidal Pérez, Francisco Researchers: Corrales Insa, Irene Altisent Roca, Carme Researcher in training: Borrás Agustí, Nina Nursing, technical and administrative staff: Ramírez Orihuela, Lorena Comes Fernández, Natalia Garcia, Iris

IP: Rafael Parra López, Francisco Vidal Pérez

Histocompatibility and immunogenetics

Clinical immunology and development of our own HLA and KIR typing protocols. PI: Herrero Mata, María José Researchers: Caro Oleas, José Luís Rudilla Salvador, Francesc Researchers in training: Enrich Randé, Emma Grau Vorster, Marta Closa Gil, Laia

IP: Maria Jose Herrero Mata

Projects

Puccini - Abordaje de las bases moleculares de los trastornos plaquetarios congénitos integrando el estudio del genoma, el transcriptoma y el uso de inteligencia artificial

IP: Irene Corrales Insa
Collaborators: -
Funding agency: Real Fundación Victoria Eugenia
Funding: 2500
Reference: RFVE/INV.CLÍNICA/2021/CORRALES
Duration: 02/01/2022 - 01/01/2023

RICORS TERAV - Teràpies avançades

IP: -
Collaborators: -
Funding agency:
Funding: 338472.2
Reference: RD21/0017/0022
Duration: 01/01/2022 - 24/12/2032

Abordaje de los trastornos hemorrágicos hereditarios de etiología compleja mediante la aplicación de una estrategia común de secuenciación de exomas

IP: Francisco Vidal Pérez
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI18/01492
Duration: 01/01/2019 - 31/12/2022

Abordaje de los trastornos hemorrágicos hereditarios de etiología compleja mediante la aplicación de una estrategia común de secuenciación de exomas

IP: Francisco Vidal Pérez
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI18/01492
Duration: 01/01/2019 - 31/12/2022

Abordaje de los trastornos hemorrágicos hereditarios de etiología compleja mediante la aplicación de una estrategia común de secuenciación de exomas

IP: Francisco Vidal Pérez
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI18/01492
Duration: 01/01/2019 - 31/12/2022

Desarrollo e implementación de nuevas herramientas de análisis molecular masivo para el abordaje integral del diagnóstico e investigación de las coagulopatías congénitas

IP: Francisco Vidal Pérez
Collaborators: Natàlia Comes Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 97405
Reference: PI15/01643
Duration: 01/01/2016 - 31/12/2019

Abordaje de los trastornos hemorrágicos hereditarios de etiología compleja mediante la aplicación de una estrategia común de secuenciación de exomas

IP: Francisco Vidal Pérez
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI18/01492
Duration: 01/01/2019 - 31/12/2022

Desarrollo e implementación de nuevas herramientas de análisis molecular masivo para el abordaje integral del diagnóstico e investigación de las coagulopatías congénitas

IP: Francisco Vidal Pérez
Collaborators: Natàlia Comes Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 97405
Reference: PI15/01643
Duration: 01/01/2016 - 31/12/2019

Desarrollo e implementación de nuevas herramientas de análisis molecular masivo para el abordaje integral del diagnóstico e investigación de las coagulopatías congénitas

IP: Francisco Vidal Pérez
Collaborators: Natàlia Comes Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 97405
Reference: PI15/01643
Duration: 01/01/2016 - 31/12/2019

Use of patient-specific induced pluripotent stem cells to improve diagnosis and treatment of hemophilia A

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Lluis Martorell Cedres, Lorena Ramirez Orihuela, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI11/03029 (ERANET)
Duration: 01/01/2012 - 30/06/2016

Aplicación de las nuevas tecnologías de secuenciación masiva al diagnóstico molecular de las coagulopatías congénitas

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Lorena Ramirez Orihuela, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 56265
Reference: PI12/01494
Duration: 01/01/2013 - 30/04/2016

Desarrollo e implementación de nuevas herramientas de análisis molecular masivo para el abordaje integral del diagnóstico e investigación de las coagulopatías congénitas

IP: Francisco Vidal Pérez
Collaborators: Natàlia Comes Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 97405
Reference: PI15/01643
Duration: 01/01/2016 - 31/12/2019

Use of patient-specific induced pluripotent stem cells to improve diagnosis and treatment of hemophilia A

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Lluis Martorell Cedres, Lorena Ramirez Orihuela, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI11/03029 (ERANET)
Duration: 01/01/2012 - 30/06/2016

Aplicación de las nuevas tecnologías de secuenciación masiva al diagnóstico molecular de las coagulopatías congénitas

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Lorena Ramirez Orihuela, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 56265
Reference: PI12/01494
Duration: 01/01/2013 - 30/04/2016

Proposal for the Continuous Proliferation & Simultaneous Maturation of Haematopoietic Stem Cells into Blood Cell Lineages (REDONTAP) Grant Agreement nº 229328

IP: Joan García López
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 406680
Reference: REDONTAP_FP7NMP2008
Duration: 01/04/2010 - 31/03/2014

Use of patient-specific induced pluripotent stem cells to improve diagnosis and treatment of hemophilia A

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Lluis Martorell Cedres, Lorena Ramirez Orihuela, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI11/03029 (ERANET)
Duration: 01/01/2012 - 30/06/2016

Aplicación de las nuevas tecnologías de secuenciación masiva al diagnóstico molecular de las coagulopatías congénitas

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Lorena Ramirez Orihuela, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 56265
Reference: PI12/01494
Duration: 01/01/2013 - 30/04/2016

Proposal for the Continuous Proliferation & Simultaneous Maturation of Haematopoietic Stem Cells into Blood Cell Lineages (REDONTAP) Grant Agreement nº 229328

IP: Joan García López
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 406680
Reference: REDONTAP_FP7NMP2008
Duration: 01/04/2010 - 31/03/2014

Use of patient-specific induced pluripotent stem cells to improve diagnosis and treatment of hemophilia A

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Lluis Martorell Cedres, Lorena Ramirez Orihuela, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI11/03029 (ERANET)
Duration: 01/01/2012 - 30/06/2016

Aplicación de las nuevas tecnologías de secuenciación masiva al diagnóstico molecular de las coagulopatías congénitas

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Lorena Ramirez Orihuela, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 56265
Reference: PI12/01494
Duration: 01/01/2013 - 30/04/2016

Función del ciclo celular en la formación de células madre pluripotentes inducidas para terapia celular en medicina regenerativa

IP: Joan García López
Collaborators: Miriam Izquierdo Sans
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 177480
Reference: RYC-2010-06512
Duration: 01/02/2011 - 31/08/2012

Ministerio de Ciencia

Aplicación de tecnologías optimizadas al diagnóstico molecular de la enfermedad de Von Willebrand: Análisis de la heterogeneidad genética.

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 91113
Reference: PI080385
Duration: 01/01/2009 - 31/03/2012

Ampliación de las instalaciones de una factoría productora de medicamentos celulares para medicina regenerativa FACTOCEL

IP: Joan García López
Collaborators: -
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 290000
Reference: PLE2009-0092
Duration: 01/11/2009 - 30/10/2012

Ministerio de Ciencia

Proposal for the Continuous Proliferation & Simultaneous Maturation of Haematopoietic Stem Cells into Blood Cell Lineages (REDONTAP) Grant Agreement nº 229328

IP: Joan García López
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 406680
Reference: REDONTAP_FP7NMP2008
Duration: 01/04/2010 - 31/03/2014

Función del ciclo celular en la formación de células madre pluripotentes inducidas para terapia celular en medicina regenerativa

IP: Joan García López
Collaborators: Miriam Izquierdo Sans
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 177480
Reference: RYC-2010-06512
Duration: 01/02/2011 - 31/08/2012

Ministerio de Ciencia

Aplicación de tecnologías optimizadas al diagnóstico molecular de la enfermedad de Von Willebrand: Análisis de la heterogeneidad genética.

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 91113
Reference: PI080385
Duration: 01/01/2009 - 31/03/2012

Ampliación de las instalaciones de una factoría productora de medicamentos celulares para medicina regenerativa FACTOCEL

IP: Joan García López
Collaborators: -
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 290000
Reference: PLE2009-0092
Duration: 01/11/2009 - 30/10/2012

Ministerio de Ciencia

Proposal for the Continuous Proliferation & Simultaneous Maturation of Haematopoietic Stem Cells into Blood Cell Lineages (REDONTAP) Grant Agreement nº 229328

IP: Joan García López
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 406680
Reference: REDONTAP_FP7NMP2008
Duration: 01/04/2010 - 31/03/2014

Collection and storage of blood samples and organ supply by creating the research infrastructure to monitor emerging pathogens and develop new screening tests STREP FP6 Grant 6487

IP: Silvia Sauleda Oliveras
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 277040
Reference: FP6-BOTIA-6487
Duration: 01/08/2006 - 31/07/2010

Caracterización serológica, inmunologica y molecular de donantes de sangre con infección oculta por virus de la hepatitis B

IP: Silvia Sauleda Oliveras
Collaborators: Lluis Castells Fusté, Marta Bes Maijo, Maria Madeleine Piron
Funding agency: Instituto de Salud Carlos III
Funding: 45980
Reference: PI070754
Duration: 01/01/2008 - 30/12/2010

Implementación y desarrollo de una nueva estrategia para la prevención de la trombocitopenia fetal/neonatal aloinmune incluyendo un protocolo de diagnóstico preimplantacional

IP: Eduardo Muñiz Díaz
Collaborators: Manuel Casellas Caro, Nuria Nogués Gálvez
Funding agency: Instituto de Salud Carlos III
Funding: 34668.92
Reference: PI070758
Duration: 01/01/2008 - 30/12/2010

Aplicación de tecnologías optimizadas al diagnóstico molecular de la enfermedad de Von Willebrand: Análisis de la heterogeneidad genética.

IP: Francisco Vidal Pérez
Collaborators: Rafael Parra López, Irene Corrales Insa, Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 91113
Reference: PI080385
Duration: 01/01/2009 - 31/03/2012

Collection and storage of blood samples and organ supply by creating the research infrastructure to monitor emerging pathogens and develop new screening tests STREP FP6 Grant 6487

IP: Silvia Sauleda Oliveras
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 277040
Reference: FP6-BOTIA-6487
Duration: 01/08/2006 - 31/07/2010

Caracterización serológica, inmunologica y molecular de donantes de sangre con infección oculta por virus de la hepatitis B

IP: Silvia Sauleda Oliveras
Collaborators: Lluis Castells Fusté, Marta Bes Maijo, Maria Madeleine Piron
Funding agency: Instituto de Salud Carlos III
Funding: 45980
Reference: PI070754
Duration: 01/01/2008 - 30/12/2010

Implementación y desarrollo de una nueva estrategia para la prevención de la trombocitopenia fetal/neonatal aloinmune incluyendo un protocolo de diagnóstico preimplantacional

IP: Eduardo Muñiz Díaz
Collaborators: Manuel Casellas Caro, Nuria Nogués Gálvez
Funding agency: Instituto de Salud Carlos III
Funding: 34668.92
Reference: PI070758
Duration: 01/01/2008 - 30/12/2010

Identificación y caracterización de células madre de la Side Population en Leucemias agudas. Papel en la resistencia a la quimioterapia.

IP: Verónica Pons Escoll
Collaborators: -
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 3000
Reference: MMCB_04_2007
Duration: 01/01/2008 - 31/12/2009

Collection and storage of blood samples and organ supply by creating the research infrastructure to monitor emerging pathogens and develop new screening tests STREP FP6 Grant 6487

IP: Silvia Sauleda Oliveras
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 277040
Reference: FP6-BOTIA-6487
Duration: 01/08/2006 - 31/07/2010

Caracterización serológica, inmunologica y molecular de donantes de sangre con infección oculta por virus de la hepatitis B

IP: Silvia Sauleda Oliveras
Collaborators: Lluis Castells Fusté, Marta Bes Maijo, Maria Madeleine Piron
Funding agency: Instituto de Salud Carlos III
Funding: 45980
Reference: PI070754
Duration: 01/01/2008 - 30/12/2010

Implementación y desarrollo de una nueva estrategia para la prevención de la trombocitopenia fetal/neonatal aloinmune incluyendo un protocolo de diagnóstico preimplantacional

IP: Eduardo Muñiz Díaz
Collaborators: Manuel Casellas Caro, Nuria Nogués Gálvez
Funding agency: Instituto de Salud Carlos III
Funding: 34668.92
Reference: PI070758
Duration: 01/01/2008 - 30/12/2010

Identificación y caracterización de células madre de la Side Population en Leucemias agudas. Papel en la resistencia a la quimioterapia.

IP: Verónica Pons Escoll
Collaborators: -
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 3000
Reference: MMCB_04_2007
Duration: 01/01/2008 - 31/12/2009

Collection and storage of blood samples and organ supply by creating the research infrastructure to monitor emerging pathogens and develop new screening tests STREP FP6 Grant 6487

IP: Silvia Sauleda Oliveras
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 277040
Reference: FP6-BOTIA-6487
Duration: 01/08/2006 - 31/07/2010

Development of preclinical testing of cord blood-derived cell therapy products Contract Number 018817

IP: Joan García López
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 5000
Reference: THERCORD-018817
Duration: 29/11/2006 - 28/11/2009

Identificación de las mutaciones responsables de hemofilia A en la población española: aplicación al desarrollo de alternativas terapéuticas

IP: Francisco Vidal Pérez
Collaborators: Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 94645
Reference: PI020809
Duration: 06/11/2002 - 28/02/2006

Collection and storage of blood samples and organ supply by creating the research infrastructure to monitor emerging pathogens and develop new screening tests STREP FP6 Grant 6487

IP: Silvia Sauleda Oliveras
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 277040
Reference: FP6-BOTIA-6487
Duration: 01/08/2006 - 31/07/2010

Development of preclinical testing of cord blood-derived cell therapy products Contract Number 018817

IP: Joan García López
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 5000
Reference: THERCORD-018817
Duration: 29/11/2006 - 28/11/2009

Blood Grouping and Genotyping: Improving patient safety and Blood Transfusion Compatibility QOL-2001-3 FP5

IP: Nuria Nogués Gálvez
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 198312
Reference: BLOODGEN
Duration: 30/06/2003 - 30/06/2006

Expresión de antígenos eritrocitarios en células transfectadas: aplicación a la identificación de anticuerpos antieritrocitarios.

IP: Nuria Nogués Gálvez
Collaborators: Rafael Parra López
Funding agency: Instituto de Salud Carlos III
Funding: 35650
Reference: PI020749
Duration: 06/11/2002 - 06/11/2005

Identificación de las mutaciones responsables de hemofilia A en la población española: aplicación al desarrollo de alternativas terapéuticas

IP: Francisco Vidal Pérez
Collaborators: Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 94645
Reference: PI020809
Duration: 06/11/2002 - 28/02/2006

Blood Grouping and Genotyping: Improving patient safety and Blood Transfusion Compatibility QOL-2001-3 FP5

IP: Nuria Nogués Gálvez
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 198312
Reference: BLOODGEN
Duration: 30/06/2003 - 30/06/2006

Expresión de antígenos eritrocitarios en células transfectadas: aplicación a la identificación de anticuerpos antieritrocitarios.

IP: Nuria Nogués Gálvez
Collaborators: Rafael Parra López
Funding agency: Instituto de Salud Carlos III
Funding: 35650
Reference: PI020749
Duration: 06/11/2002 - 06/11/2005

Identificación de las mutaciones responsables de hemofilia A en la población española: aplicación al desarrollo de alternativas terapéuticas

IP: Francisco Vidal Pérez
Collaborators: Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 94645
Reference: PI020809
Duration: 06/11/2002 - 28/02/2006

Blood Grouping and Genotyping: Improving patient safety and Blood Transfusion Compatibility QOL-2001-3 FP5

IP: Nuria Nogués Gálvez
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 198312
Reference: BLOODGEN
Duration: 30/06/2003 - 30/06/2006

Expresión de antígenos eritrocitarios en células transfectadas: aplicación a la identificación de anticuerpos antieritrocitarios.

IP: Nuria Nogués Gálvez
Collaborators: Rafael Parra López
Funding agency: Instituto de Salud Carlos III
Funding: 35650
Reference: PI020749
Duration: 06/11/2002 - 06/11/2005

Identificación de las mutaciones responsables de hemofilia A en la población española: aplicación al desarrollo de alternativas terapéuticas

IP: Francisco Vidal Pérez
Collaborators: Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 94645
Reference: PI020809
Duration: 06/11/2002 - 28/02/2006

Blood Grouping and Genotyping: Improving patient safety and Blood Transfusion Compatibility QOL-2001-3 FP5

IP: Nuria Nogués Gálvez
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 198312
Reference: BLOODGEN
Duration: 30/06/2003 - 30/06/2006

Estudio de la respuesta de linfocitos t cd4+ vhc-específicos frente a péptidos personalizados y su asociación con resolución espontánea de la infección por vhc o mediada por tratamiento antiviral.

IP: Silvia Sauleda Oliveras
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 30741.77
Reference: 01/1407
Duration: 17/07/2001 - 31/12/2002

Expresión de antígenos eritrocitarios en células transfectadas: aplicación a la identificación de anticuerpos antieritrocitarios.

IP: Nuria Nogués Gálvez
Collaborators: Rafael Parra López
Funding agency: Instituto de Salud Carlos III
Funding: 35650
Reference: PI020749
Duration: 06/11/2002 - 06/11/2005

Identificación de las mutaciones responsables de hemofilia A en la población española: aplicación al desarrollo de alternativas terapéuticas

IP: Francisco Vidal Pérez
Collaborators: Carmen Altisent Roca
Funding agency: Instituto de Salud Carlos III
Funding: 94645
Reference: PI020809
Duration: 06/11/2002 - 28/02/2006

Estudio de la respuesta de linfocitos t cd4+ vhc-específicos frente a péptidos personalizados y su asociación con resolución espontánea de la infección por vhc o mediada por tratamiento antiviral.

IP: Silvia Sauleda Oliveras
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 30741.77
Reference: 01/1407
Duration: 17/07/2001 - 31/12/2002

Publications

Long-Read Sequencing Identifies the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin Deficiency.

PMID: 35764313
Journal: THROMBOSIS AND HAEMOSTASIS
Year: 2022
Reference: Thromb Haemost. 2022 Jun 28. doi: 10.1055/s-0042-1749345.
Impact factor: 5.723
Publication type: Paper in international publication
Authors: Sanchis-Juan, Alba; Corral, Javier; Ouwehand, Willem H; Vicente, Vicente; Raymond, Frances Lucy; Vidal, Francisco; Undas, Anetta; Puurunen, Marja; Morange, Pierre-Emmanuel; Lopez-Fernandez, Maria Fernanda et al.
DOI: 10.1055/s-0042-1749345

Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry.

PMID: 35804055
Journal: BONE MARROW TRANSPLANTATION
Year: 2022
Reference: Bone Marrow Transplant. 2022 Jul 8. pii: 10.1038/s41409-022-01750-2. doi: 10.1038/s41409-022-01750-2.
Impact factor: 5.483
Publication type: Paper in international publication
Authors: Martino, Rodrigo, Fernandez-Sojo, Jesus, Horton, Roger, Cid, Joan, Azqueta, Carmen, Garcia-Buendia, Ana, Valdivia, Elena, Martorell, Lluis, Rubio-Lopez, Nuria, Codinach, Margarita et al.
DOI: 10.1038/s41409-022-01750-2

Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation.

PMID: 35614316
Journal: BONE MARROW TRANSPLANTATION
Year: 2022
Reference: Bone Marrow Transplant. 2022 May 25. pii: 10.1038/s41409-022-01722-6. doi: 10.1038/s41409-022-01722-6.
Impact factor: 5.483
Publication type: Letter whit IF
Authors: Talarn, Carme, Cid, Joan, Azqueta, Carmen, Valdivia, Elena, Martorell, Lluis, Codinach, Margarita, Marsal, Julia, Mussetti, Alberto, Esquirol, Albert, Trabazo, Maria et al.
DOI: 10.1038/s41409-022-01722-6

Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk.

PMID: 35272364
Journal: THROMBOSIS AND HAEMOSTASIS
Year: 2022
Reference: Thromb Haemost. 2022 Mar 10. doi: 10.1055/s-0041-1742169.
Impact factor: 5.723
Publication type: Paper in international publication
Authors: Lopez, Sonia, Martinez-Perez, Angel, Rodriguez-Rius, Alba, Vinuela, Ana, Brown, Andrew A, Martin-Fernandez, Laura, Vilalta, Noelia, Arus, Marc, Panousis, Nikolaos I, Buil, Alfonso et al.
DOI: 10.1055/s-0041-1742169

Fast protocol for the processing of split-thickness skin into decellularized human dermal matrix.

PMID: 34119882
Journal: TISSUE & CELL
Year: 2021
Reference: Tissue Cell. 2021 Oct;72:101572. doi: 10.1016/j.tice.2021.101572. Epub 2021 Jun 4.
Impact factor: 2.466
Publication type: Paper in international publication
Authors: Perez, M L, Castells-Sala, C, Lopez-Chicon, P, Nieto-Nicolau, N, Aiti, A, Farinas, O, Casaroli-Marano, R P, Porta, O, Vilarrodona, A et al.
DOI: 10.1016/j.tice.2021.101572

Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?

PMID: 34127808
Journal: BONE MARROW TRANSPLANTATION
Year: 2021
Reference: Bone Marrow Transplant. 2021 Oct;56(10):2489-2496. doi: 10.1038/s41409-021-01367-x. Epub 2021 Jun 14.
Impact factor: 5.483
Publication type: Paper in international publication
Authors: Linares, Monica, Ancochea, Agueda, Garcia-Rey, Enric, Garcia-Munoz, Nadia, Medina, Laura, Castillo, Nerea, Carreras, Enric, Villa, Juliana, Querol, Sergio, Valcarcel, David et al.
DOI: 10.1038/s41409-021-01367-x

Putting the spotlight on donation-related risks and donor safety - are we succeeding in protecting donors?

PMID: 33103801
Journal: VOX SANGUINIS
Year: 2021
Reference: Vox Sang. 2021 Mar;116(3):313-323. doi: 10.1111/vox.13014. Epub 2020 Oct 26.
Impact factor: 2.144
Publication type: Paper in international publication
Authors: Korkalainen, Piia, Wulff, Birgit, Fernandez-Sojo, Jesus, Eguizabal, Cristina, Urbano, Fernando, Vesga, Miguel Angel, Pozenel, Primoz, van Kraaij, Marian, Hansen, Morten Bagge, Slot, Ed et al.
DOI: 10.1111/vox.13014

Diagnostic challenges in von Willebrand disease. Report of two cases with emphasis on multimeric and molecular analysis.

PMID: 32664776
Journal: PLATELETS
Year: 2021
Reference: Platelets. 2021 Jul 4;32(5):697-700. doi: 10.1080/09537104.2020.1784403. Epub 2020 Jul 14.
Impact factor: 3.862
Publication type: Paper in international publication
Authors: Vidal, F, Corrales, I, Borras, N, Torramade-Moix, S, Palomo, M, Escolar, G, Diaz-Ricart, M, Altisent, C, Parra, R, Pino, M et al.
DOI: 10.1080/09537104.2020.1784403

Multicenter Study on Differential Human Neutrophil Antigen 2 Expression and Underlying Molecular Mechanisms.

PMID: 33173457
Journal: TRANSFUSION MEDICINE AND HEMOTHERAPY
Year: 2020
Reference: Transfus Med Hemother. 2020 Oct;47(5):385-395. doi: 10.1159/000505523. Epub 2020 Jan 22.
Impact factor: 1.937
Publication type: Paper in international publication
Authors: Kellershohn, Josina, Flesch, Brigitte K, Reil, Angelika, Nogues, Nuria, Canals, Carme, Bugert, Peter, Schulze, Torsten J, Huiskes, Elly, Porcelijn, Leendert, Hoglund, Petter et al.
DOI: 10.1159/000505523

Extrinsic modulation of integrin alpha6 and progenitor cell behavior in mesenchymal stem cells.

PMID: 32659733
Journal: Stem Cell Research
Year: 2020
Reference: Stem Cell Res. 2020 Jun 30;47:101899. doi: 10.1016/j.scr.2020.101899.
Impact factor: 4.489
Publication type: Paper in international publication
Authors: Farinas, Oscar, Savio, Andres, Vilarrodona, Anna, Casaroli-Marano, Ricardo P, de la Torre, Raquel M, Nieto-Nicolau, Nuria et al.
DOI: 10.1016/j.scr.2020.101899

Neonatal alloimmune thrombocytopenia due to anti-HPA 5a in a HPA-5a homozygous neonate.

PMID: 32763115
Journal: TRANSFUSION AND APHERESIS SCIENCE
Year: 2020
Reference: Transfus Apher Sci. 2020 Dec;59(6):102880. doi: 10.1016/j.transci.2020.102880. Epub 2020 Jul 22.
Impact factor: 1.285
Publication type: Letter or abstract
Authors: Porta, R, Serrano, P, Paltrinieri, A, Ristic, G, Canals, C, Lozano, M et al.
DOI: 10.1016/j.transci.2020.102880

Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosis.

PMID: 32493487
Journal: Stem Cell Research & Therapy
Year: 2020
Reference: Stem Cell Res Ther. 2020 Jun 3;11(1):213. doi: 10.1186/s13287-020-01726-3.
Impact factor: 5.116
Publication type: Paper in international publication
Authors: Alvarez-Palomo, Belen, Sanchez-Lopez, Luis Ignacio, Moodley, Yuben, Edel, Michael J, Serrano-Mollar, Anna et al.
DOI: 10.1186/s13287-020-01726-3

Latency Reversal Agents Affect Differently the Latent Reservoir Present in Distinct CD4+ T Subpopulations.

PMID: 31425551
Journal: PLoS Pathogens
Year: 2019
Reference: PLoS Pathog. 2019 Aug 19;15(8):e1007991. doi: 10.1371/journal.ppat.1007991. eCollection 2019 Aug.
Impact factor: 6.463
Publication type: Paper in international publication
Authors: Grau-Exposito, Judith, Luque-Ballesteros, Laura, Navarro, Jordi, Curran, Adrian, Burgos, Joaquin, Ribera, Esteban, Torrella, Ariadna, Planas, Bibiana, Badia, Rosa, Martin-Castillo, Mario et al.
DOI: 10.1371/journal.ppat.1007991

HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies: An analysis of umbilical cord blood units at the Barcelona Cord Blood Bank.

PMID: 31353832
Journal: HLA
Year: 2019
Reference: HLA. 2019 Oct;94(4):347-359. doi: 10.1111/tan.13644. Epub 2019 Aug 6.
Impact factor: 2.785
Publication type: Paper in international publication
Authors: Enrich, Emma, Campos, Eva, Martorell, Lluis, Herrero, Maria Jose, Vidal, Francisco, Querol, Sergi, Rudilla, Francesc et al.
DOI: 10.1111/tan.13644

Impact of prophylaxis on health-related quality of life of boys with hemophilia: An analysis of pooled data from 9 countries.

PMID: 31294327
Journal: Research and practice in thrombosis and haemostasi
Year: 2019
Reference: Res Pract Thromb Haemost. 2019 Apr 23;3(3):397-404. doi: 10.1002/rth2.12202. eCollection 2019 Jul.
Impact factor: 0
Publication type: Paper in international publication
Authors: Antunes, Sandra V, Usuba, Koyo, Price, Victoria E, Blanchette, Victor, Abad, Audrey, Altisent, Carmen, Buchner-Daley, Loretta, Carneiro, Jorge D A, Feldman, Brian M, Fischer, Kathelijn et al.
DOI: 10.1002/rth2.12202

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's Jelly.

PMID: 31117301
Journal: Cells
Year: 2019
Reference: Cells. 2019 May 21;8(5). pii: cells8050484. doi: 10.3390/cells8050484.
Impact factor: 5.656
Publication type: Paper in international publication
Authors: Grau-Vorster, Marta, Rodriguez, Luciano, Del Mazo-Barbara, Anna, Mirabel, Clementine, Blanco, Margarita, Codinach, Margarita, Gomez, Susana G, Querol, Sergi, Garcia-Lopez, Joan, Vives, Joaquim et al.
DOI: 10.3390/cells8050484

Immunogenicity, efficacy and safety of Nuwiq((R)) (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study.

PMID: 28815880
Journal: HAEMOPHILIA
Year: 2018
Reference: Haemophilia. 2018 Mar;24(2):211-220. doi: 10.1111/hae.13320. Epub 2017 Aug 16.
Impact factor: 2.768
Publication type: Paper in international publication
Authors: Liesner, R J, Knaub, S, Neufeld, E J, Walter, O, Belyanskaya, L, Pavlova, A, Altisent, C, Belletrutti, M J, Borel-Derlon, A, Carcao, M et al.
DOI: 10.1111/hae.13320

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.

PMID: 29924855
Journal: PLoS One
Year: 2018
Reference: PLoS One. 2018 Jun 20;13(6):e0197876. doi: 10.1371/journal.pone.0197876. eCollection 2018.
Impact factor: 2.766
Publication type: Paper in international publication
Authors: Perez-Rodriguez, Almudena, Batlle, Javier, Corrales, Irene, Borras, Nina, Rodriguez-Trillo, Angela, Loures, Esther, Cid, Ana Rosa, Bonanad, Santiago, Cabrera, Noelia, Moret, Andres et al.
DOI: 10.1371/journal.pone.0197876

Identification of the novel HLA-B*57:91 allele, by next-generation sequencing in a Spanish individual.

PMID: 29030947
Journal: HLA
Year: 2018
Reference: HLA. 2018 Jan;91(1):69-70. doi: 10.1111/tan.13159. Epub 2017 Nov 13.
Impact factor: 2.558
Publication type: Paper in international publication
Authors: Enrich, E, Campos, E, Caro-Oleas, J L, Herrero-Mata, M J, Rudilla, F et al.
DOI: 10.1111/tan.13159

HLA-DQB1*02:102, a novel allele identified by next-generation sequencing in a Spanish individual.

PMID: 29135082
Journal: HLA
Year: 2018
Reference: HLA. 2018 Feb;91(2):140-141. doi: 10.1111/tan.13174. Epub 2017 Dec 5.
Impact factor: 2.558
Publication type: Paper in international publication
Authors: Enrich, E, Herrero-Mata, M J, Rudilla, F, Caro-Oleas, J L, Mongay, L et al.
DOI: 10.1111/tan.13174

Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

PMID: 28846465
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2017
Reference: J Clin Oncol. 2017 Oct 20;35(30):3425-3432. doi: 10.1200/JCO.2017.72.6869. Epub 2017 Aug 28.
Impact factor: 24.008
Publication type: Paper in international publication
Authors: Dominietto, Alida, Castagna, Luca, Afanasyev, Boris, Robinson, Stephen, Blaise, Didier, Corradini, Paolo, Itala-Remes, Maija, Bermudez, Arancha, Forcade, Edouard, Russo, Domenico et al.
DOI: 10.1200/JCO.2017.72.6869

Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.

PMID: 29212115
Journal: THROMBOSIS AND HAEMOSTASIS
Year: 2017
Reference: Thromb Haemost. 2017 Dec;117(12):2274-2282. doi: 10.1160/TH17-01-0059. Epub 2017 Dec 6.
Impact factor: 5.627
Publication type: Paper in international publication
Authors: Escuriola-Ettingshausen, Carmen, Mancuso, Maria Elisa, Fischer, Kathelijn, Santagostino, Elena, Oldenburg, Johannes, Platokouki, Helen, Konigs, Cristoph, Carcao, Manuel, Ljung, Rolf, Petrini, Pia et al.
DOI: 10.1160/TH17-01-0059

Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA.

PMID: 28834196
Journal: JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Year: 2017
Reference: J Thromb Haemost. 2017 Nov;15(11):2188-2197. doi: 10.1111/jth.13808. Epub 2017 Sep 25.
Impact factor: 5.287
Publication type: Paper in international publication
Authors: Martorell, L, Luce, E, Vazquez, J L, Richaud-Patin, Y, Jimenez-Delgado, S, Corrales, I, Borras, N, Casacuberta-Serra, S, Weber, A, Parra, R et al.
DOI: 10.1111/jth.13808

Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors.

PMID: 26714021
Journal: EUROPEAN JOURNAL OF HAEMATOLOGY
Year: 2016
Reference: Eur J Haematol. 2016 May;96(5):461-74. doi: 10.1111/ejh.12730. Epub 2016 Feb 4.
Impact factor: 2.544
Publication type: Review in international publication
Authors: Mingot-Castellano, Maria Eva, Alvarez-Roman, Maria Teresa, Lopez-Fernandez, Maria Fernanda, Altisent-Roca, Carmen, Canaro-Hirnyk, Mariana Isabel, Jimenez-Yuste, Victor, Cid-Haro, Ana Rosa, Perez-Garrido, Rosario, Sedano-Balbas, Carmen et al.
DOI: 10.1111/ejh.12730

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.

PMID: 26755710
Journal: BLOOD
Year: 2016
Reference: Blood. 2016 Apr 7;127(14):1761-9. doi: 10.1182/blood-2015-09-669234. Epub 2016 Jan 11.
Impact factor: 11.841
Publication type: Paper in international publication
Authors: Santagostino, Elena, Martinowitz, Uri, Lissitchkov, Toshko, Pan-Petesch, Brigitte, Hanabusa, Hideji, Oldenburg, Johannes, Boggio, Lisa, Negrier, Claude, Pabinger, Ingrid, von Depka Prondzinski, Mario et al.
DOI: 10.1182/blood-2015-09-669234

Pharmacokinetics, Efficacy, and Safety of Nonacog Alfa in Previously Treated Patients with Moderately Severe to Severe Hemophilia B.

PMID: 26969334
Journal: CLINICAL THERAPEUTICS
Year: 2016
Reference: Clin Ther. 2016 Apr;38(4):936-44. doi: 10.1016/j.clinthera.2016.02.015. Epub 2016 Mar 8.
Impact factor: 2.925
Publication type: Paper in international publication
Authors: Korth-Bradley, Joan M, Rendo, Pablo, Smith, Lynne, Altisent, Carmen et al.
DOI: 10.1016/j.clinthera.2016.02.015

Sodium content in products used to treat haemophilia.

PMID: 27228069
Journal: HAEMOPHILIA
Year: 2016
Reference: Haemophilia. 2016 Jul;22(4):e324-7. doi: 10.1111/hae.12948. Epub 2016 May 26.
Impact factor: 2.673
Publication type: Letter or abstract
Authors: Altisent, C, Martorell, M, de la Sierra, A et al.
DOI: 10.1111/hae.12948

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.

PMID: 25649244
Journal: HAEMOPHILIA
Year: 2015
Reference: Haemophilia. 2015 Jul;21(4):458-64. doi: 10.1111/hae.12618. Epub 2015 Feb 4.
Impact factor: 2.603
Publication type: Paper in international publication
Authors: Garcia-Dasi, M, Aznar, J A, Jimenez-Yuste, V, Altisent, C, Bonanad, S, Mingot, E, Lucia, F, Gimenez, F, Lopez, M Fernanda, Marco, P et al.
DOI: 10.1111/hae.12618

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.

PMID: 25527565
Journal: HAEMATOLOGICA
Year: 2015
Reference: Haematologica. 2015 Mar;100(3):e84-6. doi: 10.3324/haematol.2014.115709. Epub 2014 Dec 19.
Impact factor: 5.814
Publication type: Letter whit IF
Authors: Nijdam, Annelies, Altisent, Carmen, Carcao, Manuel D, Cid, Ana R, Claeyssens-Donadel, Segolene, Kurnik, Karin, Ljung, Rolf, Nolan, Beatrice, Petrini, Pia, Platokouki, Helen et al.
DOI: 10.3324/haematol.2014.115709

Similar bleeding phenotype in young children with haemophilia A or B: a cohort study.

PMID: 24893572
Journal: HAEMOPHILIA
Year: 2014
Reference: Haemophilia. 2014 Nov;20(6):747-55. doi: 10.1111/hae.12470. Epub 2014 Jun 3.
Impact factor: 2.468
Publication type: Paper in international publication
Authors: Chalmers, E, Clausen, N, Petrini, P, Claeyssens-Donadel, S, Gouw, S C, Liesner, R, Altisent, C, Auerswald, G, Carcao, M, Cid, A et al.
DOI: 10.1111/hae.12470

Proteomic analysis of platelet N-glycoproteins in PMM2-CDG patients.

PMID: 24388574
Journal: THROMB RES
Year: 2014
Reference: Thromb Res. 2014 Mar;133(3):412-7. doi: 10.1016/j.thromres.2013.12.024. Epub 2013 Dec 21.
Impact factor: 2.427
Publication type: Paper in international publication
Authors: Sevivas, T, Vicente, V, Jaeken, J, Freson, K, Corral, J, Altisent, C, Perez-Duenas, B, Rivera, J, Lozano, M L, de la Morena-Barrio, M E et al.
DOI: 10.1016/j.thromres.2013.12.024

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.

PMID: 23553768
Journal: BLOOD
Year: 2013
Reference: Blood. 2013 May 16;121(20):4046-55. doi: 10.1182/blood-2012-09-457036. Epub 2013 Apr 3.
Impact factor: 9.06
Publication type: Paper in international publication
Authors: Chambost, Herve, Kurnik, Karin, Liesner, Ri, Petrini, Pia, Platokouki, Helen, Altisent, Carmen, Oldenburg, Johannes, Nolan, Beatrice, Garrido, Rosario Perez, Mancuso, M Elisa et al.
DOI: 10.1182/blood-2012-09-457036

GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients.

PMID: 24139637
Journal: Orphanet Journal of Rare Diseases
Year: 2013
Reference: Orphanet J Rare Dis. 2013 Oct 20;8:170. doi: 10.1186/1750-1172-8-170.
Impact factor: 4.315
Publication type: Paper in international publication
Authors: de la Morena-Barrio, Maria E, Hernandez-Caselles, Trinidad, Corral, Javier, Garcia-Lopez, Roberto, Martinez-Martinez, Irene, Perez-Duenas, Belen, Altisent, Carmen, Sevivas, Teresa, Kristensen, Soren R, Guillen-Navarro, Encarna et al.
DOI: 10.1186/1750-1172-8-170

High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methods.

PMID: 22315491
Journal: Haematologica-The Hematology Journal
Year: 2012
Reference: Haematologica. 2012 Jul;97(7):1003-7. doi: 10.3324/haematol.2011.055285. Epub 2012 Feb 7.
Impact factor: 6.424
Publication type: Paper in international publication
Authors: Corrales, Irene, Catarino, Susana, Ayats, Julia, Arteta, David, Altisent, Carmen, Parra, Rafael, Vidal, Francisco et al.
DOI: 10.3324/haematol.2011.055285

Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10-year follow-up study.

PMID: 22429259
Journal: HAEMOPHILIA
Year: 2012
Reference: Haemophilia. 2012 Sep;18(5):789-93. doi: 10.1111/j.1365-2516.2012.02772.x. Epub 2012 Mar 19.
Impact factor: 2.597
Publication type: Paper in international publication
Authors: , , , , et al.
DOI: 10.1111/j.1365-2516.2012.02772.x

The optimal mode of delivery for the haemophilia carrier expecting an affected infant: further considerations.

PMID: 21371199
Journal: HAEMOPHILIA
Year: 2011
Reference: Haemophilia. 2011 Sep;17(5):818-9. doi: 10.1111/j.1365-2516.2011.02505.x. Epub 2011 Mar 4.
Impact factor: 2.364
Publication type: Letter or abstract
Authors: , , , , et al.
DOI: 10.1111/j.1365-2516.2011.02505.x

The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients' platelets and leukocytes.

PMID: 21251206
Journal: JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Year: 2011
Reference: J Thromb Haemost. 2011 Apr;9(4):679-88. doi: 10.1111/j.1538-7836.2011.04204.x.
Impact factor: 5.439
Publication type: Paper in international publication
Authors: , , , , et al.
DOI: 10.1111/j.1538-7836.2011.04204.x

The 'royal disease' mutation in a Spanish patient.

PMID: 20626617
Journal: JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Year: 2010
Reference: J Thromb Haemost. 2010 Oct;8(10):2316-7. doi: 10.1111/j.1538-7836.2010.03977.x.
Impact factor: 6.069
Publication type: Letter or abstract
Authors: Ramirez, L, Altisent, C, Parra, R, Vidal, F et al.
DOI: 10.1111/j.1538-7836.2010.03977.x

Integration of molecular and clinical data of 40 unrelated VWD families in a Spanish locus-specific mutation database. First release including 58 mutations.

PMID: 20801902
Journal: Haematologica-The Hematology Journal
Year: 2010
Reference: Haematologica. 2010 Nov;95(11):1982-4. Epub 2010 Aug 26.
Impact factor: 6.416
Publication type: Letter or abstract
Authors: , , , , , et al.
DOI: 10.3324/haematol.2010.028977

Rapid molecular diagnosis of von Willebrand disease by direct sequencing. Detection of 12 novel putative mutations in VWF gene.

PMID: 19277422
Journal: THROMBOSIS AND HAEMOSTASIS
Year: 2009
Reference: Thromb Haemost. 2009 Mar;101(3):570-6.
Impact factor: 3.803
Publication type: Paper in international publication
Authors: Corrales, Irene, Ramirez, Lorena, Altisent, Carme, Parra, Rafael, Vidal, Francisco et al.
DOI:

Thesis

Umbilical cord blood platelet rich plasma derivatives for therapeutic applications and development of clinical trials fr treatment of skin and ocular ulcers

PhD student: Dinara Samarkanova
Director/s: Sergi Querol Giner
University: Universitat Autònoma de Barcelona
Year: 2020

TGF-B1 y otras moléculas como biomarcadores de consolidación ósea en pseudoartrosis hipertrófica de huesos largos

PhD student: Daniel Chaverri Fierro
Director/s: Juan Minguell Moñart, Joaquim Vives Armengol
University: Universitat Autònoma de Barcelona
Year: 2019

TGF-B1 y otras moléculas como biomarcadores de consolidación ósea en pseudoartrosis hipertrófica de huesos largos

PhD student: Daniel Chaverri Fierro
Director/s: Juan Minguell Moñart, Joaquim Vives Armengol
University: Universitat Autònoma de Barcelona
Year: 2019

Cinética y factores predictivos de estudio de la cinética de la reconstitución inmune y sus factores predictivos en el trasplante de sangre de cordón umbilical

PhD student: Nerea Castillo Flores
Director/s: Sergi Querol Giner
University: Universitat Autònoma de Barcelona
Year: 2017

Reparació prenatal del mielomeningocele mitjançant cèl·lules mesenquimals estromals de líquid amniòtic en model oví

PhD student: Margarita Codinach Creus
Director/s: César Galo García Fontecha, Joaquim Vives Armengol
University: Universitat Autònoma de Barcelona
Year: 2015

Búsqueda de Biomarcadores asociados a la conversión a esclerosis múltiple en pacientes con síndromes clínicos aislados

PhD student: Ester Canto Puig
Director/s: Manuel Comabella Lopez, Xavier Montalban Gairín
University: Universitat Autònoma de Barcelona
Year: 2014

Aplicació de tecnologies optimitzades al diagnòstic molecular de la malaltia de von Willebrand per l’estudi de la relació genotip-fenotip

PhD student: Irene Corrales Insa
Director/s: Francisco Vidal Pérez
University: Universitat de Barcelona
Year: 2011

Caracteritzación de la glicoproteína CD8 mutante responsable de la Deficiencia Familiar de CD8. Estudios de otras inmunodeficiencias que afectan a la función de los linfocitos T citotóxicos

PhD student: Cecilia González Santesteban
Director/s:
University: Universitat Autònoma de Barcelona
Year: 2009

Job offers

Postdoctoral
Start date:
10/02/2022
End date:
28/02/2022
Document: Download
PROJECT MANAGER-Transfusional Medicine Research Group (VHIR-BST)
Start date:
10/12/2021
End date:
24/12/2021
Document: Download
Postdoctoral position in cell therapy-Transfusional Medicine Research Group (VHIR-BST)
Start date:
10/12/2021
End date:
24/12/2021
Document: Download